Long-term Efficacy and Safety of Canakinumab in Patients With Active Systemic Juvenile Idiopathic Arthritis (SJIA): Results From a Phase III

被引：0

作者：

Brunner, Hermine ^{[1
]}

Ruperto, Nicolino ^{[2
]}

Quartier, Pierre ^{[3
]}

Constantin, Tamas ^{[2
]}

Alexeeva, Ekaterina ^{[2
]}

Kone-Paut, Isabelle ^{[4
]}

Marzan, Katherine ^{[5
]}

Wulffraat, Nico ^{[2
]}

Schneider, Rayfel ^{[5
]}

Padeh, Shai ^{[6
]}

Chasnyk, Vyacheslav ^{[6
]}

Wouters, Carine ^{[6
]}

Kuemmerle-Deschner, Jasmin B. ^{[6
]}

Kallinich, Tilmann ^{[6
]}

Lauwerys, Bernard ^{[7
,8
]}

Haddad, Elie

Nasonov, Evgeny L. ^{[6
]}

Trachana, Maria ^{[6
]}

Vougiouka, Olga ^{[6
]}

Leon, Karolynn ^{[9
]}

Vritzali, Eleni ^{[10
]}

Lheritier, Karine ^{[11
]}

Martini, Alberto ^{[6
]}

Lovell, Daniel ^{[5
]}

机构：

[1] PRCSG, Rheumatol, Cincinnati, OH USA

[2] PRINTO Ist Gaslini, Genoa, Italy

[3] Necker Enfants Malad Hosp, Paris, France

[4] Univ Paris Sud, Hop Kremlin Bicetre, Paris, France

[5] PRCSG, Cincinnati, OH USA

[6] PRINTO Ist Gaslini, Genoa, Italy

[7] Clin Univ St Luc, Brussels, Belgium

[8] Catholic Univ Louvain, Brussels, Belgium

[9] Novartis Pharmaceut, E Hanover, NJ USA

[10] Novartis Pharma AG, Immunol & Dermatol Franchise, Basel, Switzerland

[11] Novartis Pharma AG, Basel, Switzerland

来源：

ARTHRITIS & RHEUMATOLOGY | 2017年 / 69卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：64 / 66

页数：3

共 50 条

[1] Long-Term Efficacy and Safety of Canakinumab in Patients with Active Systemic Juvenile Idiopathic Arthritis (SJIA): Results from a PHASE III Extension Study
Brunner, Hermine I.
Ruperto, Nicolino
Quartier, Pierre
Constantin', Tamas
Alexeeva, Ekaterina
Kone-Paut, Isabelle
Marzan, Katherine
Wulffraat, Nico
Schneider, Rayfel
Padeh, Shai
Chasnyk, Vyacheslav
Wouters, Carine
Kuemmerle-Deschner, Jasmin B.
Kallinich, Tilmann
Lauwerys, Bernard
Haddad, Elie
Nasonov, Evgeny L.
Trachana, Maria
Vougiouka, Olga
Leon, Karolynn
Vritzali, Eleni
Lheritier, Karine
Martinis, Alberto
Lovell, Daniel J.
[J]. ARTHRITIS & RHEUMATOLOGY, 2016, 68
[2] Long-Term Efficacy and Safety of Canakinumab in Children with Systemic Juvenile Idiopathic Arthritis
Alexeeva, Ekaterina
Denisova, Rina
Dvoryakovskaya, Tatyana
Isaeva, Ksenia
Kriulin, Ivan
Alshevskaya, Alina
Moskalev, Andrey
[J]. ARTHRITIS & RHEUMATOLOGY, 2019, 71
[3] Long-term efficacy and safety of canakinumab in the treatment of systemic juvenile idiopathic arthritis in Japanese patients: Results from an open-label Phase III study
Iwata, Naomi
Nishimura, Kenichi
Hara, Ryoki
Imagawa, Tomoyuki
Shimizu, Masaki
Tomiita, Minako
Umebayashi, Hiroaki
Takei, Syuji
Seko, Noriko
Wakabayashi, Ryota
Yokota, Shumpei
[J]. MODERN RHEUMATOLOGY, 2023, 33 (06) : 1162 - 1170
[4] TREATING TO TARGET WITH CANAKINUMAB IN PATIENTS WITH ACTIVE SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS: RESULTS FROM THE LONG-TERM EXTENSION THE PHASE III PIVOTAL TRIAL
Ruperto, N.
Brunner, H. I.
Quartier, P.
Constantin, T.
Alexeeva, E.
Kone-Paut, I.
Marzan, K.
Wulffraat, N.
Schneider, R.
Padeh, S.
Chasnyk, V.
Wouters, C.
Kuemmerle-Deschner, J. B.
Kallinich, T.
Lauwerys, B.
Haddad, E.
Nasonov, E.
Trachana, M.
Vougiouka, O.
Leon, K.
Speziale, A.
Lheritier, K.
Martini, A.
Lovell, D.
[J]. ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 401 - 402
[5] LONG-TERM EFFICACY AND SAFETY OF CANAKINUMAB IN PATIENTS WITH SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS: RESULTS FROM A SINGLE-CENTER STUDY
Alexeeva, E.
Krekhova, E.
Dvoryakovskaya, T.
Isaeva, K.
Chomakhidze, A.
Chistyakova, E.
Lomakina, O.
Denisova, R.
Mamutova, A.
Fetisova, A.
Gautier, M.
Vankova, D.
Shingarova, M.
Kriulin, I.
Alshevskaya, A.
Moskalev, A.
[J]. ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1776 - 1777
[6] Efficacy and Safety of Canakinumab in Patients with Systemic Juvenile Idiopathic Arthritis: Results from an Open-Label Long-Term Followup Study
Brunner, Hermine L.
Ruperto, Nicolino
Quartier, Pierre
Constantin, Tamas
Alexeeva, Ekaterina
Schneider, Rayfel
Kone-Paut, Isabelle
Schikler, Kenneth
Marzan, Katherine
Wulffraat, Nico
Padeh, Shai
Chasnyk, Vyacheslav
Wouters, Carine
Kuemmerle-Deschner, Jasmin B.
Kallinich, Tilmann
Lauwerys, Bernard
Haddad, Elie
Nasonov, Evgeny L.
Trachana, Maria
Vougiouka, Olga
Leon, Karolynn
Speziale, Antonio
Lheritier, Karine
Vritzali, Eleni
Lovell, Daniel J.
Martini, Alberto
[J]. ARTHRITIS & RHEUMATOLOGY, 2016, 68
[7] Canakinumab in patients with systemic juvenile idiopathic arthritis and active systemic features: results from the 5-year long-term extension of the phase III pivotal trials
Ruperto, Nicolino
Brunner, Hermine I.
Quartier, Pierre
Constantin, Tamas
Wulffraat, Nico M.
Horneff, Gerd
Kasapcopur, Ozgur
Schneider, Rayfel
Anton, Jordi
Barash, Judith
Berner, Reinhard
Corona, Fabrizia
Cuttica, Ruben
Fouillet-desjonqueres, Marine
Fischbach, Michel
Foster, Helen E.
Foell, Dirk
Radominski, Sebastiao C.
Ramanan, Athimalaipet V.
Trauzeddel, Ralf
Unsal, Erbil
Levy, Jeremy
Vritzali, Eleni
Martini, Alberto
Lovell, Daniel J.
[J]. ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 (12) : 1710 - 1719
[8] LONG-TERM EFFICACY AND SAFETY OF CANAKINUMAB IN PATIENTS WITH SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS (SJIA): 5-YEAR FOLLOW-UP OF AN OPEN-LABEL TRIAL
Ruperto, N.
Brunner, H. I.
Quartier, P.
Constantin, T.
Alexeeva, E.
Schneider, R.
Kone-Paut, I.
Schikler, K.
Marzan, K.
Wulffraat, N.
Padeh, S.
Chasnyk, V.
Wouters, C.
Kuemmerle-Deschner, J. B.
Kallinich, T.
Lauwerys, B.
Haddad, E.
Nasonov, E.
Trachana, M.
Vougiouka, O.
Leon, K.
Speziale, A.
Lheritier, K.
Martini, A.
Lovell, D.
[J]. ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 265 - 266
[9] Efficacy and Safety of Canakinumab in Patients With Systemic Juvenile Idiopathic Arthritis: Results From an Open-Label, Long-Term Follow-up Study
Brunner, Hermine
Ruperto, Nicolino
Quartier, Pierre
Constantin, Tamas
Alexeeva, Ekaterina
Schneider, Rayfel
Kone-Paut, Isabelle
Schikler, Kenneth N.
Marzan, Katherine
Wulffraat, Nico
Padeh, Shai
Chasnyk, Vyacheslav
Wouters, Carine
Kuemmerle-Deschner, Jasmin B.
Kallinich, Tilmann
Lauwerys, Bernard
Haddad, Elie
Nasonov, Evgeny L.
Trachana, Maria
Vougiouka, Olga
Leon, Karolynn
Speziale, Antonio
Lheritier, Karine
Vritzali, Eleni
Martini, Alberto
Lovell, Daniel
[J]. ARTHRITIS & RHEUMATOLOGY, 2017, 69 : 7 - 8
[10] Long-Term Safety and Efficacy of Rilonacept in Patients With Systemic Juvenile Idiopathic Arthritis
Lovell, Daniel J.
Giannini, Edward H.
Reiff, Andreas O.
Kimura, Yukiko
Li, Suzanne
Hashkes, Philip J.
Wallace, Carol A.
Onel, Karen B.
Foell, Dirk
Wu, Richard
Biedermann, Stephanie
Hamilton, Jennifer D.
Radin, Allen R.
[J]. ARTHRITIS AND RHEUMATISM, 2013, 65 (09): : 2486 - 2496

← 1 2 3 4 5 →